Diagnostic Imaging's Weekly Scan: January 1-January 7
Check out the top radiology content of the past week.
Diagnostic Imaging's Weekly Scan is your chance to catch up on the latest radiology content, from new research and device news to the latest case quizzes and conference reports. Review the slideshow below to see this week's top content:
Click the arrows above to view top radiology content from the past week.
First Hyperpolarized MRI Contrast Agent Gets FDA Approval
An inhaled contrast agent used with magnetic resonance imaging (MRI), Xenoview™ (xenon Xe 129 hyperpolarized) reportedly provides regional mapping of lung ventilation without patient exposure to ionizing radiation. READ MORE
Can MRI Provide Greater Clarity of Suspected BI-RADS 3 Lesions?
Emerging research suggests that magnetic resonance imaging (MRI) may help downgrade nearly 10 percent of suspected BI-RADS 3 lesions from ultrasound imaging. READ MORE
Is PSMA PET/CT More Beneficial than Bone Scintigraphy in Detecting Bone Lesions in Cases of High-Risk Prostate Cancer?
A new comparative study found the use of prostate-specific membrane antigen (PSMA) positron emission tomography (PET/CT) led to treatment changes in nearly 20 percent of patients with high-risk prostate cancer. READ MORE
What a New Study Reveals About Breast Density Awareness
In a recent interview from the Radiological Society of North America (RSNA) conference, Mary Yamashita, M.D. discussed a variety of findings from a survey of over 8,000 women about breast density awareness, challenges with current breast density notiification after mammography exams, and the ongoing need to educate patients as well as referring providers on breast density awareness. WATCH NOW
Can Deep Learning Enhance Ultrasound Assessment of Hepatic Steatosis in Patients with NAFLD?
In a new prospective study, an emerging deep learning model, which incorporates parametric mapping with quantitative ultrasound to estimate liver fat fraction, demonstrated a 90 percent sensitivity rate and a 91 percent specificity rate for diagnosing hepatic steatosis in patients with non-alcoholic fatty liver disease (NAFLD). READ MORE
